Trials / Completed
CompletedNCT05957198
Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease
Assessment of the Oxygen Use and Future Outcomes Associated With Oxygen Use in Patient With Fibrotic ILD
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 114,921 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe initiation and use of oxygen therapy among patients with fibrotic Interstitial Lung Disease (ILD) and to assess the impact of oxygen therapy on clinical outcomes among patients with fibrotic ILD.
Conditions
Timeline
- Start date
- 2023-07-25
- Primary completion
- 2023-09-26
- Completion
- 2023-09-26
- First posted
- 2023-07-24
- Last updated
- 2024-11-21
- Results posted
- 2024-11-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05957198. Inclusion in this directory is not an endorsement.